THE EFFECTS OF MAINTENANCE THERAPY WITH UPADACITINIB ON ABDOMINAL PAIN, BOWEL URGENCY, AND FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U--ACHIEVE MAINTENANCE RESULTS

被引：0
|
作者：
Danese, Silvio
Tran, Jacinda
D'Haens, Geert R.
Rubin, David T.
Aoyama, Nobuo
Zhou, Wen
James, Barbara
Yao, Xuan
Gonzalez, Yuri Sanchez
Panaccione, Remo
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1463
引用
收藏
页码：S972 / S972
页数：1
相关论文
共 50 条
  • [41] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [42] EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY
    Peyrin-Biroulet, Laurent
    Loftus, Edward V.
    Danese, Silvio
    Vermeire, Severine
    Sandborn, William J.
    Fogel, Ronald P.
    Nijhawan, Sandeep
    Kempinski, Radoslaw
    Filip, Rafal
    Hospodarskyy, Ihor
    McNally, John
    Yun, Chohee
    Zhao, Sally
    Liu, Xiaopeng
    Tasset, Chantal T.
    Besuyen, Robin
    Watanabe, Mamoru
    Schreiber, Stefan
    Rogler, Gerhrad
    Hibi, Toshifumi
    Feagan, Brian G.
    GASTROENTEROLOGY, 2021, 160 (06) : S350 - S350
  • [43] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [44] CORRELATION OF HISTOLOGICAL ASSESSMENT OF MUCOSAL HEALING WITH LONG-TERM CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH UPADACITINIB: RESULTS FROM PHASE 3 U-ACHIEVE MAINTENANCE TRIAL
    Parke, Gareth
    Ungaro, Ryan C.
    Danese, Silvio
    Abreu, Maria T.
    Arenson, Ethan
    Zhou, Wen
    Ilo, Dapo
    Laroux, Stephen
    Deng, Huiwen
    Gonzalez, Yuri Sanchez
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2022, 162 (07) : S970 - S970
  • [45] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: Results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, S.
    Deng, H.
    Gonzalez, Y. S.
    Peyrin-Biroulet, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 157 - 157
  • [46] Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
    Loftus, Edward V.
    Takeuchi, Ken
    Gao, Xiang
    Panaccione, Remo
    Danese, Silvio
    Ilo, Dapo
    Finney-Hayward, Tricia
    Phillips, Charles
    Yao, Xuan
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S359 - S359
  • [47] Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis
    Panaccione, Remo
    Danese, Silvio
    Zhou, Wen
    Klaff, Justin
    Ilo, Dapo
    Yao, Xuan
    Levy, Gweneth
    Higgins, Peter D. R.
    Loftus Jr, Edward V.
    Chen, Su
    Gonzalez, Yuri Sanchez
    Leonard, Carolyn
    Hebuterne, Xavier
    Lindsay, James O.
    Cao, Qian
    Nakase, Hiroshi
    Colombel, Jean-Frederic
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (03) : 393 - 408
  • [48] Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Week 44 Results From the Phase 3 QUASAR Maintenance Study
    Panes, Julian
    Dignass, Axel
    Hisamatsu, Tadakazu
    Yarandi, Shadi
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Sridhar, Sunandini
    Branigan, Patrick
    Wilson, Rebbecca
    Zhang, Hongyan
    Magro, Fernando
    Jairath, Vipul
    Feagan, Brian G.
    Lichtenstein, Gary R.
    Rubin, David T.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1041 - S1041
  • [49] Corticosteroid-Sparing Effect in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab Maintenance Therapy
    Laharie, David
    Siegel, Corey A.
    Samaan, Karen
    Fischer, Deborah
    Morris, Nathan
    Redondo, Isabel
    Dulai, Parambir S.
    Jairath, Vipul
    Gisbert, Javier P.
    Matsuoka, Katsuyoshi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S635 - S635
  • [50] CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY
    Laharie, D.
    Siegel, C. A.
    Samaan, K.
    Fisher, D. A.
    Morris, N.
    Redondo, I.
    Dulai, P. S.
    Jairath, V.
    Gisbert, J. P.
    Matsuoka, K.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S163 - S164
12345